Hsieh · Scientific reports 2020 · Ex vivo and in vitro laboratory study · n=?

Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway.

Cited 54 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Bench, cell culture, and ex vivo animal tissue experiment with no human data.

PubMed 33051481 · doi:10.1038/s41598-020-74022-y · record verified 2026-08-26

What was done

Researchers investigated the vasomotor and molecular signaling effects of the peptide BPC 157 using isolated rat aortic rings (with intact or removed endothelium), a three-dimensional vascular smooth muscle cell model, and cultured vascular endothelial cells. They measured nitric oxide (NO) production via DAF-FM DA fluorescence, assessed endothelial cell migration, tested pathway dependency using NO inhibitors (L-NAME, hemoglobin) and a Src inhibitor, and evaluated Src, Cav-1, and eNOS phosphorylation and Cav-1-eNOS binding via co-immunoprecipitation.

What was found

BPC 157 induced concentration-dependent vasorelaxation in isolated rat aorta that was markedly attenuated by endothelium removal and blocked by L-NAME or hemoglobin. High peptide concentrations produced slight vasorelaxation without endothelium, but BPC 157 showed no direct relaxation in the 3D smooth muscle model. BPC 157 stimulated intracellular NO generation, promoted endothelial cell migration, enhanced phosphorylation of Src, Cav-1, and eNOS, and decreased binding between Cav-1 and eNOS; phosphorylation was prevented by Src inhibition. The abstract reports directional findings only and contains no numerical data, concentrations, or effect sizes.

Why it matters

This study outlines a specific molecular mechanism (activation of the upstream Src kinase leading to Cav-1/eNOS dissociation and NO release) by which BPC 157 modulates vascular tone and stimulates endothelial cell migration.

Limits

Findings are limited to ex vivo rat tissue and cell culture models; systemic hemodynamic effects and human pharmacokinetic or clinical efficacy were not evaluated. The abstract omits sample sizes (number of aortic rings or experimental replicates) and quantitative statistical values.

Cited by